تحضير وتحسين الاولانزابين كنظام جسيمات نانومترية عبر الجلد لعلاج الفصام

Abdulqader AA, Al-Khedairy EBH. Formulation and evaluation of fast dissolving tablets of taste-masked ondansetron hydrochloride by solid dispersion. Iraqi J Pharm Sci. 2017;26(1):50-60. doi: 10.31351/vol26iss1pp50-60. DOI: https://doi.org/10.31351/vol26iss1pp50-60

Rubbens J, Mols R, Brouwers J, Augustijns P. Exploring gastric drug absorption in fasted and fed state rats. Int J Pharm. 2018;548(1):636–6641. doi: 10.1016/j.ijpharm.2018.07.017. DOI: https://doi.org/10.1016/j.ijpharm.2018.07.017

Adepu S, Ramakrishna S. Controlled drug delivery systems: Current status and future directions. Molecules. 2021;26(19):5905. doi: 10.3390/molecules26195905. DOI: https://doi.org/10.3390/molecules26195905

Szunerits S, Boukherroub R. Heat: A highly efficient skin enhancer for transdermal drug delivery. Front Bioeng Biotechnol. 2018;6(15):1-13. doi: 10.3389/fbioe.2018.00015. DOI: https://doi.org/10.3389/fbioe.2018.00015

Afzal O, Altamimi ASA, Nadeem MS, Alzarea SI, Almalki WH, Tariq A. Nanoparticles in drug delivery: From history to therapeutic applications. Nanomaterials (Basel). 2022;12(24):4494. doi: 10.3390/nano12244494. DOI: https://doi.org/10.3390/nano12244494

Alhagiesa AW, Ghareeb MM. Formulation and characterization of nimodipine nanoparticles for the Enhancement of solubility and dissolution rate. Iraqi J Pharm Sci. 2021;30(2):143-152. doi: 10.31351/vol30iss2pp143-152. DOI: https://doi.org/10.31351/vol30iss2pp143-152

Muhesen RA, Rajab NA. Formulation and characterization of olmesartan medoxomil as a nanoparticle. Res J Pharm Technol. 2023;16(7):1-7. doi: 10.52711/0974-360X.2023.00547. DOI: https://doi.org/10.52711/0974-360X.2023.00547

Zubiaur P, Soria-Chacartegui P, Villapalos-García G, Gordillo-Perdomo JJ, Abad-Santos F. The pharmacogenetics of treatment with olanzapine. Pharmacogenomics. 2021;22(14):939-958. doi: 10.2217/pgs-2021-005. DOI: https://doi.org/10.2217/pgs-2021-0051

Alwan RM, Rajab NA. Nanosuspensions of selexipag: Formulation, characterization, and in vitro evaluation. Iraqi J Pharm Sci. 2021;30(1):144-153. doi: 10.31351/vol30iss1pp144-153. DOI: https://doi.org/10.31351/vol30iss1pp144-153

Hamed HE, Hussein AA. Preparation, in vitro and ex-vivo evaluation of mirtazapine nanosuspension and nanoparticles incorporated in orodispersible tablets. Iraqi J Pharm Sci. 2020;29(1):62–75. doi: 10.31351/vol29iss1pp62-75. DOI: https://doi.org/10.31351/vol29iss1pp62-75

Sreelola V, Sailaja AK, Pharmacy M. Preparation and characterisation of ibuprofen loaded polymeric nanoparticles by solvent evaporation technique. Int J Pharmacy Pharm Sci. 2014;6(8):416-421.

Mahmood HS, Ghareeb MM, Hamzah ZO. Formulation and in-vitro evaluation of flurbiprofen nanoparticles for transdermal delivery. J Complement Med Res. 2020;11(5):223.

Dalvi SV, Dave RN. Controlling particle size of a poorly water-soluble drug using ultrasound and stabilizers in antisolvent precipitation. Ind Eng Chem Res. 2009;48(16):7581-7593. doi: 10.1021/ie900248f. DOI: https://doi.org/10.1021/ie900248f

Rajab NA, Jassem NA. A design and in vitro evaluation of azilsartan medoxomil as a self-dispersible dry nanosuspension. Der Pharmacia Sinica. 2018;9(1):12-32. DOI: https://doi.org/10.22159/ijpps.2017v9i7.18917

Maher EM, Ali AM, Salem HF, Abdelrahman AA. In vitro/in vivo evaluation of an optimized fast dissolving oral film containing olanzapine co-amorphous dispersion with selected carboxylic acids. Drug Deliv. 2016;23(8):3088-3100. doi: 10.3109/10717544.2016.1153746. DOI: https://doi.org/10.3109/10717544.2016.1153746

Abbas IK, Abd AlHammid SN. Preparation and characterization of bilastine solid self-nanoemulsion using liquisolid technique. Al-Rafidain J Med Sci. 2023;5:78-85. doi: 10.54133/ajms.v5i.160. DOI: https://doi.org/10.54133/ajms.v5i.160

Sehgal N, Gupta NV, Gowda DV. Fabrication and evaluation of solid dispersion containing Glibenclamide. Asian J Pharm Clin Res. 2018;11(8):158-161. doi: 10.22159/ajpcr. 2018.v11i8.26236. DOI: https://doi.org/10.22159/ajpcr.2018.v11i8.26236

Muneer R, Hashmet MR, Pourafshary P. DLVO modelling to predict critical salt concentration to initiate fines migration pre-and post-nano fluid treatment in sandstones. SPE J. 2022; 27:1915-1929. doi: 10.2118/209588-PA. DOI: https://doi.org/10.2118/209588-PA

Cherukuri S, Batchu UR, Mandava K, Cherukuri V. Formulation and evaluation of transdermal drug delivery of topiramate. Int J Pharm Investig. 2017;7(1):10-17. doi: 10.4103/jphi.JPHI_35_16. DOI: https://doi.org/10.4103/jphi.JPHI_35_16

Ajit Shankarrao K, Dhairysheel Mahadeo G. Formulation and in-vitro evaluation of orally disintegrating tablets of olanzapine-2-Hydroxypropyl-β-Cyclodextrin inclusion complex. Iran J Pharm Res. 2010;9(4):335.

Hussien RM, Ghareeb MM. Formulation and characterization of isradipine nanoparticle for dissolution enhancement. Iraqi J Pharm Sci. 2021;30(1):218-225. doi: 10.31351/vol30iss1pp218-225. DOI: https://doi.org/10.31351/vol30iss1pp218-225

Salatin S, Barar J, Barzegar-Jalali M. Development of a nanoprecipitation method for the entrapment of a very water soluble drug into Eudragit RL nanoparticles. Res Pharm Sci. 2017;12(1):1-14. doi: 10.4103/1735-5362.199041. DOI: https://doi.org/10.4103/1735-5362.199041

Liu D, Xu H, Tian B, Yuan K, Pan H, Ma S. Fabrication of carvedilol nanosuspensions through the anti-solvent precipitation-ultrasonication method for the improvement of dissolution rate and oral bioavailability. AAPS Pharm SciTech. 2012;13(1):295-304. doi: 10.1208/s12249-011-9750-7. DOI: https://doi.org/10.1208/s12249-011-9750-7

Mishra R, Mir SR, Amin S. Polymeric nanoparticles for improved bioavailability of cilnidipine. Int J Pharm Pharm Sci. 2017;9(4):129-139. doi: 10.22159/ijpps.2017v9i4.15786. DOI: https://doi.org/10.22159/ijpps.2017v9i4.15786

Xu L, Chu Z, Zhang J. Steric effects in the deposition mode and drug-delivering efficiency of nanocapsule-based multilayer films. ACS Omega. 2022;7(34):30321-30332. doi: 10.1021/acsomega.2c03591. DOI: https://doi.org/10.1021/acsomega.2c03591

Rudrangi SRS, Trivedi V, Mitchell JC. Preparation of olanzapine and methyl--cyclodextrin complexes using a single-step, organic solvent-free supercritical fluid process: An approach to enhance the solubility and dissolution properties. IJPR. 2015;494(1):408-416. doi: 10.1016/j.ijpharm.2015.08.062. DOI: https://doi.org/10.1016/j.ijpharm.2015.08.062

Ismail ST, Al-Kotaji MM, Khayrallah AA. Formulation and evaluation of nystatin microparticles as a sustained release system. Iraqi J Pharm Sci. 2015;24(2):1-10. doi: 10.31351/vol24iss2pp1-10. DOI: https://doi.org/10.31351/vol24iss2pp1-10

Ali AH, Abd-Alhammid SN. Enhancement of solubility and Improvement of dissolution rate of atorvastatin calcium prepared as nanosuspension. Iraqi J PharmSci. 2019;28(2):46-57. doi: 10.31351/vol28iss2pp46-57. DOI: https://doi.org/10.31351/vol28iss2pp46-57

Yang H, Teng F, Wang P, Tian B. Investigation of a nanosuspension stabilized by Soluplus® to improve bioavailability. Int J Pharm. 2014;30;477(1-2):88-95. doi: 10.1016/j.ijpharm.2014.10.025. DOI: https://doi.org/10.1016/j.ijpharm.2014.10.025

Tiwari M, Chawla G, Bansal AK. Quantification of olanzapine polymorphs using powder X-ray diffraction technique. J Pharm Biomed Anal. 2007;43(3):865-872. doi: 10.1016/j.jpba.2006.08.030. DOI: https://doi.org/10.1016/j.jpba.2006.08.030

Cho HW, Baek SH, Lee BJ, Jin HE. Orodispersible polymer films with the poorly water-soluble drug, olanzapine: hot-melt pneumatic extrusion for single-process 3D printing. Pharmaceutics. 2020;12(8):692. doi: 10.3390/pharmaceutics12080692. DOI: https://doi.org/10.3390/pharmaceutics12080692

Krishnamoorthy V, Suchandrasen, Verma Priya Ranjan Prasad VPR. Physicochemical characterization and in vitro dissolution behavior of olanzapine-mannitol solid dispersions. Braz J Pharm Sci. 2012;48(2):244-255. doi: 10.1590/S1984-82502012000200008. DOI: https://doi.org/10.1590/S1984-82502012000200008